nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.369	1	CbGbCtD
Levobunolol—Timolol—ADRB3—type 2 diabetes mellitus	0.00418	0.276	CrCbGaD
Levobunolol—Nadolol—ADRB3—type 2 diabetes mellitus	0.00332	0.22	CrCbGaD
Levobunolol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.00317	0.21	CrCbGaD
Levobunolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.00209	0.138	CrCbGaD
Levobunolol—Palpitations—Glimepiride—type 2 diabetes mellitus	0.00122	0.00262	CcSEcCtD
Levobunolol—Confusional state—Glipizide—type 2 diabetes mellitus	0.00122	0.00262	CcSEcCtD
Levobunolol—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.00121	0.00261	CcSEcCtD
Levobunolol—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00121	0.0026	CcSEcCtD
Levobunolol—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.00121	0.00259	CcSEcCtD
Levobunolol—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.0012	0.00259	CcSEcCtD
Levobunolol—Dizziness—Tolazamide—type 2 diabetes mellitus	0.0012	0.00259	CcSEcCtD
Levobunolol—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.0012	0.00257	CcSEcCtD
Levobunolol—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00119	0.00257	CcSEcCtD
Levobunolol—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00119	0.00257	CcSEcCtD
Levobunolol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00119	0.00256	CcSEcCtD
Levobunolol—Shock—Glipizide—type 2 diabetes mellitus	0.00119	0.00255	CcSEcCtD
Levobunolol—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.00119	0.00255	CcSEcCtD
Levobunolol—Ataxia—Losartan—type 2 diabetes mellitus	0.00119	0.00255	CcSEcCtD
Levobunolol—Depression—Orlistat—type 2 diabetes mellitus	0.00118	0.00255	CcSEcCtD
Levobunolol—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00116	0.00249	CcSEcCtD
Levobunolol—Alopecia—Glyburide—type 2 diabetes mellitus	0.00116	0.00249	CcSEcCtD
Levobunolol—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00115	0.00248	CcSEcCtD
Levobunolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.00114	0.0754	CrCbGaD
Levobunolol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00114	0.00245	CcSEcCtD
Levobunolol—Headache—Tolazamide—type 2 diabetes mellitus	0.00114	0.00245	CcSEcCtD
Levobunolol—Confusional state—Glimepiride—type 2 diabetes mellitus	0.00114	0.00244	CcSEcCtD
Levobunolol—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.00113	0.00243	CcSEcCtD
Levobunolol—Headache—Linagliptin—type 2 diabetes mellitus	0.00113	0.00243	CcSEcCtD
Levobunolol—Syncope—Bromocriptine—type 2 diabetes mellitus	0.00112	0.0024	CcSEcCtD
Levobunolol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00111	0.0024	CcSEcCtD
Levobunolol—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.00111	0.00239	CcSEcCtD
Levobunolol—Shock—Glimepiride—type 2 diabetes mellitus	0.00111	0.00238	CcSEcCtD
Levobunolol—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.00111	0.00238	CcSEcCtD
Levobunolol—Cerebrovascular accident—Ramipril—type 2 diabetes mellitus	0.0011	0.00237	CcSEcCtD
Levobunolol—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.0011	0.00236	CcSEcCtD
Levobunolol—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.00109	0.00235	CcSEcCtD
Levobunolol—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00108	0.00233	CcSEcCtD
Levobunolol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00108	0.00232	CcSEcCtD
Levobunolol—Nausea—Tolazamide—type 2 diabetes mellitus	0.00108	0.00232	CcSEcCtD
Levobunolol—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00108	0.00231	CcSEcCtD
Levobunolol—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00107	0.00231	CcSEcCtD
Levobunolol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00105	0.00226	CcSEcCtD
Levobunolol—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.00105	0.00226	CcSEcCtD
Levobunolol—Nausea—Acarbose—type 2 diabetes mellitus	0.00104	0.00223	CcSEcCtD
Levobunolol—Pain—Glipizide—type 2 diabetes mellitus	0.00103	0.00222	CcSEcCtD
Levobunolol—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00103	0.00222	CcSEcCtD
Levobunolol—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00103	0.00222	CcSEcCtD
Levobunolol—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00102	0.0022	CcSEcCtD
Levobunolol—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00101	0.00218	CcSEcCtD
Levobunolol—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.001	0.00216	CcSEcCtD
Levobunolol—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.001	0.00216	CcSEcCtD
Levobunolol—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.001	0.00216	CcSEcCtD
Levobunolol—Nausea—Nateglinide—type 2 diabetes mellitus	0.001	0.00215	CcSEcCtD
Levobunolol—Bradycardia—Metformin—type 2 diabetes mellitus	0.001	0.00215	CcSEcCtD
Levobunolol—Shock—Bromocriptine—type 2 diabetes mellitus	0.000999	0.00215	CcSEcCtD
Levobunolol—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000998	0.00215	CcSEcCtD
Levobunolol—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000994	0.00214	CcSEcCtD
Levobunolol—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000989	0.00213	CcSEcCtD
Levobunolol—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000975	0.0021	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000963	0.00207	CcSEcCtD
Levobunolol—Pain—Sitagliptin—type 2 diabetes mellitus	0.00096	0.00207	CcSEcCtD
Levobunolol—Urticaria—Glipizide—type 2 diabetes mellitus	0.000959	0.00206	CcSEcCtD
Levobunolol—Alopecia—Valsartan—type 2 diabetes mellitus	0.000953	0.00205	CcSEcCtD
Levobunolol—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000953	0.00205	CcSEcCtD
Levobunolol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000949	0.00204	CcSEcCtD
Levobunolol—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000944	0.00203	CcSEcCtD
Levobunolol—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000943	0.00203	CcSEcCtD
Levobunolol—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000943	0.00203	CcSEcCtD
Levobunolol—Alopecia—Orlistat—type 2 diabetes mellitus	0.000942	0.00203	CcSEcCtD
Levobunolol—Confusional state—Glyburide—type 2 diabetes mellitus	0.000936	0.00201	CcSEcCtD
Levobunolol—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000928	0.002	CcSEcCtD
Levobunolol—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000925	0.00199	CcSEcCtD
Levobunolol—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000919	0.00198	CcSEcCtD
Levobunolol—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000918	0.00198	CcSEcCtD
Levobunolol—Headache—Repaglinide—type 2 diabetes mellitus	0.000914	0.00197	CcSEcCtD
Levobunolol—Shock—Glyburide—type 2 diabetes mellitus	0.000914	0.00197	CcSEcCtD
Levobunolol—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000912	0.00196	CcSEcCtD
Levobunolol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000912	0.00196	CcSEcCtD
Levobunolol—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000906	0.00195	CcSEcCtD
Levobunolol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000903	0.00194	CcSEcCtD
Levobunolol—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000898	0.00193	CcSEcCtD
Levobunolol—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000895	0.00192	CcSEcCtD
Levobunolol—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000893	0.00192	CcSEcCtD
Levobunolol—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000892	0.00192	CcSEcCtD
Levobunolol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000889	0.00191	CcSEcCtD
Levobunolol—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00087	0.00187	CcSEcCtD
Levobunolol—Hypotension—Glyburide—type 2 diabetes mellitus	0.000868	0.00187	CcSEcCtD
Levobunolol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000866	0.00186	CcSEcCtD
Levobunolol—Asthenia—Glipizide—type 2 diabetes mellitus	0.000866	0.00186	CcSEcCtD
Levobunolol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000864	0.00186	CcSEcCtD
Levobunolol—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.00086	0.00185	CcSEcCtD
Levobunolol—Pruritus—Glipizide—type 2 diabetes mellitus	0.000854	0.00184	CcSEcCtD
Levobunolol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000852	0.00183	CcSEcCtD
Levobunolol—Syncope—Valsartan—type 2 diabetes mellitus	0.000842	0.00181	CcSEcCtD
Levobunolol—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000841	0.00181	CcSEcCtD
Levobunolol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000837	0.0018	CcSEcCtD
Levobunolol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000834	0.00179	CcSEcCtD
Levobunolol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00083	0.00179	CcSEcCtD
Levobunolol—Palpitations—Valsartan—type 2 diabetes mellitus	0.00083	0.00179	CcSEcCtD
Levobunolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000829	0.00178	CcSEcCtD
Levobunolol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000828	0.00178	CcSEcCtD
Levobunolol—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000828	0.00178	CcSEcCtD
Levobunolol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000827	0.00178	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000826	0.00178	CcSEcCtD
Levobunolol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000826	0.00178	CcSEcCtD
Levobunolol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000825	0.00178	CcSEcCtD
Levobunolol—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000825	0.00177	CcSEcCtD
Levobunolol—Palpitations—Orlistat—type 2 diabetes mellitus	0.00082	0.00176	CcSEcCtD
Levobunolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000819	0.00176	CcSEcCtD
Levobunolol—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.00081	0.00174	CcSEcCtD
Levobunolol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000808	0.00174	CcSEcCtD
Levobunolol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000807	0.00174	CcSEcCtD
Levobunolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000805	0.00173	CcSEcCtD
Levobunolol—Chest pain—Valsartan—type 2 diabetes mellitus	0.000799	0.00172	CcSEcCtD
Levobunolol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000798	0.00172	CcSEcCtD
Levobunolol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000797	0.00171	CcSEcCtD
Levobunolol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000791	0.0017	CcSEcCtD
Levobunolol—Chest pain—Orlistat—type 2 diabetes mellitus	0.00079	0.0017	CcSEcCtD
Levobunolol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000779	0.00168	CcSEcCtD
Levobunolol—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000779	0.00168	CcSEcCtD
Levobunolol—Alopecia—Losartan—type 2 diabetes mellitus	0.000771	0.00166	CcSEcCtD
Levobunolol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00077	0.00166	CcSEcCtD
Levobunolol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000768	0.00165	CcSEcCtD
Levobunolol—Syncope—Metformin—type 2 diabetes mellitus	0.000767	0.00165	CcSEcCtD
Levobunolol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000765	0.00165	CcSEcCtD
Levobunolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000764	0.00164	CcSEcCtD
Levobunolol—Headache—Glipizide—type 2 diabetes mellitus	0.000756	0.00163	CcSEcCtD
Levobunolol—Palpitations—Metformin—type 2 diabetes mellitus	0.000755	0.00163	CcSEcCtD
Levobunolol—Shock—Valsartan—type 2 diabetes mellitus	0.000754	0.00162	CcSEcCtD
Levobunolol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000751	0.00162	CcSEcCtD
Levobunolol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000749	0.00161	CcSEcCtD
Levobunolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000745	0.0016	CcSEcCtD
Levobunolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000743	0.0016	CcSEcCtD
Levobunolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000742	0.0016	CcSEcCtD
Levobunolol—Urticaria—Glyburide—type 2 diabetes mellitus	0.000738	0.00159	CcSEcCtD
Levobunolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000729	0.00157	CcSEcCtD
Levobunolol—Chest pain—Metformin—type 2 diabetes mellitus	0.000728	0.00157	CcSEcCtD
Levobunolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000724	0.00156	CcSEcCtD
Levobunolol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000723	0.00156	CcSEcCtD
Levobunolol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000721	0.00155	CcSEcCtD
Levobunolol—Nausea—Glipizide—type 2 diabetes mellitus	0.000717	0.00154	CcSEcCtD
Levobunolol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000716	0.00154	CcSEcCtD
Levobunolol—Pain—Gliclazide—type 2 diabetes mellitus	0.000713	0.00153	CcSEcCtD
Levobunolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000709	0.00153	CcSEcCtD
Levobunolol—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000707	0.00152	CcSEcCtD
Levobunolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000705	0.00152	CcSEcCtD
Levobunolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000703	0.00151	CcSEcCtD
Levobunolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000695	0.0015	CcSEcCtD
Levobunolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000688	0.00148	CcSEcCtD
Levobunolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000687	0.00148	CcSEcCtD
Levobunolol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000687	0.00148	CcSEcCtD
Levobunolol—Shock—Metformin—type 2 diabetes mellitus	0.000686	0.00148	CcSEcCtD
Levobunolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000684	0.00147	CcSEcCtD
Levobunolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000683	0.00147	CcSEcCtD
Levobunolol—Syncope—Losartan—type 2 diabetes mellitus	0.000681	0.00147	CcSEcCtD
Levobunolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00068	0.00146	CcSEcCtD
Levobunolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000672	0.00145	CcSEcCtD
Levobunolol—Palpitations—Losartan—type 2 diabetes mellitus	0.000671	0.00144	CcSEcCtD
Levobunolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000669	0.00144	CcSEcCtD
Levobunolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000668	0.00144	CcSEcCtD
Levobunolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000667	0.00144	CcSEcCtD
Levobunolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000667	0.00143	CcSEcCtD
Levobunolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000666	0.00143	CcSEcCtD
Levobunolol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000662	0.00143	CcSEcCtD
Levobunolol—Alopecia—Ramipril—type 2 diabetes mellitus	0.000661	0.00142	CcSEcCtD
Levobunolol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000657	0.00141	CcSEcCtD
Levobunolol—Hypotension—Metformin—type 2 diabetes mellitus	0.000652	0.0014	CcSEcCtD
Levobunolol—Shock—Irbesartan—type 2 diabetes mellitus	0.000648	0.00139	CcSEcCtD
Levobunolol—Pain—Orlistat—type 2 diabetes mellitus	0.000647	0.00139	CcSEcCtD
Levobunolol—Chest pain—Losartan—type 2 diabetes mellitus	0.000646	0.00139	CcSEcCtD
Levobunolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000636	0.00137	CcSEcCtD
Levobunolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000635	0.00137	CcSEcCtD
Levobunolol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000626	0.00135	CcSEcCtD
Levobunolol—Confusional state—Losartan—type 2 diabetes mellitus	0.000625	0.00134	CcSEcCtD
Levobunolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000624	0.00134	CcSEcCtD
Levobunolol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000622	0.00134	CcSEcCtD
Levobunolol—Salbutamol—CYP3A4—type 2 diabetes mellitus	0.00062	0.041	CrCbGaD
Levobunolol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000615	0.00132	CcSEcCtD
Levobunolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000614	0.00132	CcSEcCtD
Levobunolol—Shock—Losartan—type 2 diabetes mellitus	0.00061	0.00131	CcSEcCtD
Levobunolol—Urticaria—Valsartan—type 2 diabetes mellitus	0.000609	0.00131	CcSEcCtD
Levobunolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000603	0.0013	CcSEcCtD
Levobunolol—Urticaria—Orlistat—type 2 diabetes mellitus	0.000601	0.00129	CcSEcCtD
Levobunolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000598	0.00129	CcSEcCtD
Levobunolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000591	0.00127	CcSEcCtD
Levobunolol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00059	0.00127	CcSEcCtD
Levobunolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000587	0.00126	CcSEcCtD
Levobunolol—Syncope—Ramipril—type 2 diabetes mellitus	0.000584	0.00126	CcSEcCtD
Levobunolol—Headache—Glyburide—type 2 diabetes mellitus	0.000582	0.00125	CcSEcCtD
Levobunolol—Hypotension—Losartan—type 2 diabetes mellitus	0.000579	0.00125	CcSEcCtD
Levobunolol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000575	0.00124	CcSEcCtD
Levobunolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000575	0.00124	CcSEcCtD
Levobunolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000572	0.00123	CcSEcCtD
Levobunolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000571	0.00123	CcSEcCtD
Levobunolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000564	0.00121	CcSEcCtD
Levobunolol—Pain—Irbesartan—type 2 diabetes mellitus	0.000563	0.00121	CcSEcCtD
Levobunolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000558	0.0012	CcSEcCtD
Levobunolol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000556	0.0012	CcSEcCtD
Levobunolol—Urticaria—Metformin—type 2 diabetes mellitus	0.000554	0.00119	CcSEcCtD
Levobunolol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000554	0.00119	CcSEcCtD
Levobunolol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000552	0.00119	CcSEcCtD
Levobunolol—Nausea—Glyburide—type 2 diabetes mellitus	0.000552	0.00119	CcSEcCtD
Levobunolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000551	0.00119	CcSEcCtD
Levobunolol—Asthenia—Valsartan—type 2 diabetes mellitus	0.00055	0.00118	CcSEcCtD
Levobunolol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000543	0.00117	CcSEcCtD
Levobunolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000543	0.00117	CcSEcCtD
Levobunolol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000542	0.00117	CcSEcCtD
Levobunolol—Confusional state—Ramipril—type 2 diabetes mellitus	0.000536	0.00115	CcSEcCtD
Levobunolol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000536	0.00115	CcSEcCtD
Levobunolol—Pain—Losartan—type 2 diabetes mellitus	0.00053	0.00114	CcSEcCtD
Levobunolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000524	0.00113	CcSEcCtD
Levobunolol—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000523	0.00113	CcSEcCtD
Levobunolol—Shock—Ramipril—type 2 diabetes mellitus	0.000523	0.00112	CcSEcCtD
Levobunolol—Headache—Gliclazide—type 2 diabetes mellitus	0.000522	0.00112	CcSEcCtD
Levobunolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000518	0.00111	CcSEcCtD
Levobunolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000511	0.0011	CcSEcCtD
Levobunolol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000507	0.00109	CcSEcCtD
Levobunolol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000501	0.00108	CcSEcCtD
Levobunolol—Asthenia—Metformin—type 2 diabetes mellitus	0.000501	0.00108	CcSEcCtD
Levobunolol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000496	0.00107	CcSEcCtD
Levobunolol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000495	0.00107	CcSEcCtD
Levobunolol—Pruritus—Metformin—type 2 diabetes mellitus	0.000494	0.00106	CcSEcCtD
Levobunolol—Urticaria—Losartan—type 2 diabetes mellitus	0.000492	0.00106	CcSEcCtD
Levobunolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000485	0.00104	CcSEcCtD
Levobunolol—Headache—Valsartan—type 2 diabetes mellitus	0.00048	0.00103	CcSEcCtD
Levobunolol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000477	0.00103	CcSEcCtD
Levobunolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000477	0.00103	CcSEcCtD
Levobunolol—Headache—Orlistat—type 2 diabetes mellitus	0.000474	0.00102	CcSEcCtD
Levobunolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000474	0.00102	CcSEcCtD
Levobunolol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000472	0.00102	CcSEcCtD
Levobunolol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000466	0.001	CcSEcCtD
Levobunolol—Dizziness—Metformin—type 2 diabetes mellitus	0.000461	0.000993	CcSEcCtD
Levobunolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000457	0.000982	CcSEcCtD
Levobunolol—Nausea—Valsartan—type 2 diabetes mellitus	0.000455	0.000979	CcSEcCtD
Levobunolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00045	0.000969	CcSEcCtD
Levobunolol—Nausea—Orlistat—type 2 diabetes mellitus	0.00045	0.000968	CcSEcCtD
Levobunolol—Asthenia—Losartan—type 2 diabetes mellitus	0.000445	0.000957	CcSEcCtD
Levobunolol—Pruritus—Losartan—type 2 diabetes mellitus	0.000438	0.000943	CcSEcCtD
Levobunolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000438	0.000942	CcSEcCtD
Levobunolol—Headache—Metformin—type 2 diabetes mellitus	0.000437	0.00094	CcSEcCtD
Levobunolol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000435	0.000937	CcSEcCtD
Levobunolol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000424	0.000912	CcSEcCtD
Levobunolol—Urticaria—Ramipril—type 2 diabetes mellitus	0.000422	0.000908	CcSEcCtD
Levobunolol—Nausea—Metformin—type 2 diabetes mellitus	0.000414	0.000892	CcSEcCtD
Levobunolol—Headache—Irbesartan—type 2 diabetes mellitus	0.000412	0.000888	CcSEcCtD
Levobunolol—Dizziness—Losartan—type 2 diabetes mellitus	0.00041	0.000882	CcSEcCtD
Levobunolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000391	0.000842	CcSEcCtD
Levobunolol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000391	0.000842	CcSEcCtD
Levobunolol—Headache—Losartan—type 2 diabetes mellitus	0.000388	0.000835	CcSEcCtD
Levobunolol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000381	0.00082	CcSEcCtD
Levobunolol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000376	0.000809	CcSEcCtD
Levobunolol—Nausea—Losartan—type 2 diabetes mellitus	0.000368	0.000792	CcSEcCtD
Levobunolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000364	0.000782	CcSEcCtD
Levobunolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000358	0.0237	CrCbGaD
Levobunolol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000351	0.000756	CcSEcCtD
Levobunolol—Headache—Ramipril—type 2 diabetes mellitus	0.000333	0.000716	CcSEcCtD
Levobunolol—Nausea—Ramipril—type 2 diabetes mellitus	0.000316	0.000679	CcSEcCtD
Levobunolol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000237	0.0157	CrCbGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000121	0.000798	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000119	0.000787	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000119	0.000786	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000118	0.000781	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000117	0.000773	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000117	0.000773	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000116	0.000765	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000116	0.000765	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000115	0.000756	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000115	0.000756	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000113	0.000748	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000113	0.000748	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000113	0.000747	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000112	0.000742	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000111	0.000731	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.00011	0.000729	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.00011	0.000726	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.00011	0.000725	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000109	0.000722	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000108	0.000713	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000107	0.000709	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000107	0.000707	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000107	0.000707	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000107	0.000706	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000107	0.000704	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000105	0.000695	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000105	0.000694	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000105	0.000692	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000105	0.000691	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000104	0.000688	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000103	0.000681	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000103	0.00068	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000103	0.000679	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000102	0.000674	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000101	0.000666	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	9.99e-05	0.000659	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.94e-05	0.000656	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.8e-05	0.000647	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.75e-05	0.000644	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.72e-05	0.000642	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.72e-05	0.000641	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.68e-05	0.000639	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.59e-05	0.000633	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.58e-05	0.000633	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.56e-05	0.000631	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.54e-05	0.00063	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.54e-05	0.00063	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.51e-05	0.000628	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.47e-05	0.000625	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.38e-05	0.000619	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.36e-05	0.000618	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.36e-05	0.000617	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.33e-05	0.000616	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.16e-05	0.000604	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TLE4—type 2 diabetes mellitus	9.11e-05	0.000601	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.91e-05	0.000588	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.86e-05	0.000584	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.77e-05	0.000579	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.71e-05	0.000575	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.66e-05	0.000572	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.58e-05	0.000566	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.52e-05	0.000562	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.47e-05	0.000559	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.4e-05	0.000555	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.29e-05	0.000547	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.28e-05	0.000547	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.22e-05	0.000543	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.11e-05	0.000535	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.89e-05	0.000521	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.81e-05	0.000516	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.74e-05	0.000511	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.74e-05	0.000511	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.71e-05	0.000509	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.64e-05	0.000504	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.63e-05	0.000504	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.58e-05	0.0005	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.58e-05	0.0005	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.55e-05	0.000498	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.55e-05	0.000498	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.53e-05	0.000497	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.53e-05	0.000497	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.49e-05	0.000494	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.47e-05	0.000493	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.42e-05	0.00049	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.38e-05	0.000487	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.38e-05	0.000487	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.37e-05	0.000486	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.37e-05	0.000486	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.33e-05	0.000484	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.26e-05	0.000479	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.16e-05	0.000473	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	7.05e-05	0.000465	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.01e-05	0.000462	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.9e-05	0.000455	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.89e-05	0.000455	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.8e-05	0.000449	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.74e-05	0.000445	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.73e-05	0.000444	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.68e-05	0.000441	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.65e-05	0.000439	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.64e-05	0.000439	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.58e-05	0.000434	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.55e-05	0.000432	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.54e-05	0.000432	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.53e-05	0.000431	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.52e-05	0.00043	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.5e-05	0.000429	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.49e-05	0.000428	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.4e-05	0.000423	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.4e-05	0.000423	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.38e-05	0.000421	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.38e-05	0.000421	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.35e-05	0.000419	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.26e-05	0.000413	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	6.26e-05	0.000413	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.21e-05	0.00041	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.12e-05	0.000404	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.08e-05	0.000401	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.05e-05	0.000399	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.03e-05	0.000398	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.03e-05	0.000398	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.94e-05	0.000392	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.92e-05	0.000391	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.9e-05	0.00039	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.9e-05	0.00039	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.87e-05	0.000387	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.85e-05	0.000386	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.84e-05	0.000386	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.82e-05	0.000384	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.74e-05	0.000379	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.74e-05	0.000379	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.65e-05	0.000373	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.62e-05	0.000371	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.59e-05	0.000369	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.59e-05	0.000369	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.53e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.49e-05	0.000363	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.37e-05	0.000355	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.32e-05	0.000351	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.3e-05	0.00035	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.23e-05	0.000345	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.23e-05	0.000345	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.2e-05	0.000344	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.18e-05	0.000342	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.15e-05	0.00034	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.13e-05	0.000339	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.12e-05	0.000338	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.12e-05	0.000338	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.03e-05	0.000332	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.02e-05	0.000331	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.9e-05	0.000323	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.81e-05	0.000317	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.81e-05	0.000317	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.79e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.7e-05	0.000311	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.7e-05	0.00031	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.55e-05	0.0003	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.51e-05	0.000298	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.45e-05	0.000294	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.45e-05	0.000294	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.45e-05	0.000294	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.43e-05	0.000292	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.41e-05	0.000291	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.41e-05	0.000291	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.36e-05	0.000288	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.35e-05	0.000287	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.35e-05	0.000287	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.33e-05	0.000286	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.31e-05	0.000285	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.3e-05	0.000284	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.28e-05	0.000283	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.27e-05	0.000282	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.23e-05	0.000279	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.21e-05	0.000278	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.19e-05	0.000276	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.14e-05	0.000273	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.1e-05	0.000271	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.02e-05	0.000265	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.02e-05	0.000265	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.93e-05	0.000259	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.85e-05	0.000254	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.78e-05	0.00025	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.77e-05	0.000249	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.7e-05	0.000244	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.7e-05	0.000244	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.62e-05	0.000239	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.52e-05	0.000233	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.52e-05	0.000232	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.51e-05	0.000232	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.45e-05	0.000228	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.45e-05	0.000228	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.4e-05	0.000224	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.38e-05	0.000223	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.37e-05	0.000222	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.37e-05	0.000222	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.33e-05	0.00022	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.24e-05	0.000214	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.17e-05	0.000209	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.07e-05	0.000203	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3e-05	0.000198	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.94e-05	0.000194	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.89e-05	0.000191	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.88e-05	0.00019	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.84e-05	0.000188	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.84e-05	0.000188	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.83e-05	0.000187	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.83e-05	0.000187	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.78e-05	0.000184	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.78e-05	0.000183	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.77e-05	0.000183	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.7e-05	0.000178	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.64e-05	0.000174	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.58e-05	0.00017	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.58e-05	0.00017	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.52e-05	0.000166	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.52e-05	0.000166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.43e-05	0.00016	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.37e-05	0.000157	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.21e-05	0.000146	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.19e-05	0.000144	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.17e-05	0.000143	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.16e-05	0.000143	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.14e-05	0.000141	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.13e-05	0.00014	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.07e-05	0.000136	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.05e-05	0.000135	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.02e-05	0.000134	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.01e-05	0.000132	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2e-05	0.000132	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.96e-05	0.00013	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.91e-05	0.000126	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.87e-05	0.000123	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.86e-05	0.000123	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.82e-05	0.00012	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.7e-05	0.000112	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.67e-05	0.00011	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.67e-05	0.00011	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.63e-05	0.000108	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.28e-05	8.48e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.26e-05	8.29e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.18e-05	7.82e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.16e-05	7.65e-05	CbGpPWpGaD
